Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Omeros Corp (NQ: OMER )

7.070 USD -0.360 (-4.85%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 29, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 559,036
Open 7.550
Bid (Size) 7.100 (1)
Ask (Size) 7.650 (28)
Prev. Close 7.430
Today's Range 7.040 - 7.594
52wk Range 5.450 - 23.85
Shares Outstanding 62,542,268
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Omeros Corporation Reports Third Quarter 2021 Financial Results
Omeros Corporation (Nasdaq: OMER), a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market as well... 
From Business Wire News Releases
Omeros Announces Results From Nearly Three-Year Follow-up of Patients in Phase 2 IgA Nephropathy Trial
Omeros Corporation (Nasdaq: OMER) today announced results of long-term follow-up from the Phase 2 clinical trial evaluating its MASP-2 inhibitor narsoplimab in patients with IgA nephropathy. Treatment... 
From Business Wire News Releases

Performance

YTD
-51.31%
-51.31%
1 Month
+2.76%
+2.76%
3 Month
-54.94%
-54.94%
6 Month
-53.94%
-53.94%
1 Year
-39.00%
-39.00%

More News

Read More
Omeros’ Narsoplimab Stabilized Kidney Function and Reduced Urinary Complement Proteins in a Patient with IgA Vasculitis
From Business Wire News Releases
Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2021
From Business Wire News Releases
We Did The Math IHE Can Go To $233
Tags ETFs
From ETF Channel
Omeros: Q3 Earnings Insights
Tags Market News Benzinga OMER
From Benzinga
Earnings Outlook For Omeros
Tags Market News BZI/EP OMER
From Benzinga
Omeros' Narsoplimab Shows Improved, Stabilized Renal Function At Three Years
Tags Small Cap Briefs General
From Benzinga
10 Biggest Price Target Changes For Tuesday
Tags Price Target Changes SNOW WMT
From Benzinga
Omeros Stock Falls As FDA Asks For More Clinical Narsoplimab Data In HSCT-TMA
Tags Trading Ideas Biotech Briefs
From Benzinga
Notable Monday Option Activity: OMER, MP, SNV
Tags Stocks
From Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.